Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BioAccess Oy
OY
Active
Y-tunnus 3390102-4
Valtakatu 13-A10
Computer consultancy and computer facilities management activities · NACE 6220
Est. 2023
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
EUR 54K
+26% vs 2024
EBITDA margin
38.1%
+122% vs 2024
Equity ratio
82.1%
Financial strength
Net profit 2025
EUR 16K
+123% vs 2024
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
EUR 54K
+26%
EBITDA
EUR 21K
+122%
Net profit
EUR 16K
+123%
Total assets
EUR 30K
+181%
Equity
EUR 24K
+184%
Employees
1
—
Company information
Legal name
BioAccess Oy
Y-tunnus number
3390102-4
Legal form
Osakeyhtiö
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
14. syyskuuta 2023
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
IT-järjestelmien ja niiden ala- ja tukijärjestelmien rakentaminen, korjaus, huolto ja koulutus.
Contact
Address
Valtakatu 13-A10
Phone
+3580440770442
Email
bioaccess@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Computer consultancy and computer facilities management activities
Companies in Lappeenranta
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
EUR thousands
Item
2024
2025
Revenue
43
54
Staff expenses
−6
−8
EBITDA
9
21
Depreciation & amort.
−0
−0
EBIT
9
21
Net financials
0
0
Profit before tax
9
21
Tax
2
4
Net profit
7
16
Balance sheet
EUR thousands
Item
2024
2025
Total assets
11
30
Equity
9
24
Long-term debt
0
0
Short-term debt
2
5
Total debt
2
5
Financial ratios
5-year trend
EBITDA margin
38.1%
This company
15.8%
Market median
+141% vs market
2024
2025
Equity ratio
82.1%
This company
38.2%
Market median
+115% vs market
2024
2025
Return on equity
67.6%
This company
18.4%
Market median
+267% vs market
2024
2025
Net profit margin
30.5%
This company
8.1%
Market median
+277% vs market
2024
2025
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
2024
2025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-09-14 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JS
Jyrki Sakari Heinonen
Chief Executive Officer
Chief Executive Officer
2023
EM
Eila Maria Heinonen
Deputy Member
Deputy Member
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BioAccess Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Jyrki Sakari Heinonen
Chief Executive Officer
0 companies
Eila Maria Heinonen
Deputy Member
0 companies